Jerome M. Feldman

Jerome M. Feldman's AcademicInfluence.com Rankings

Jerome M. Feldman

Philosophy

#9111

World Rank

#12620

Historical Rank

Logic

#6104

World Rank

#7587

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Jerome M. Feldman's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Jerome M. Feldman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jerome M. Feldman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography. (1995) (331)
Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid. (1985) (206)
Bronchial carcinoid tumors: a retrospective analysis of 126 patients. (1992) (205)
Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors. (1986) (162)
Carcinoid tumors and the carcinoid syndrome. (1989) (139)
Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma. (2003) (138)
Urinary serotonin in the diagnosis of carcinoid tumors. (1986) (129)
Inhibition of hypoglycemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide. (1973) (125)
The pharmacology of sulfonylureas. (1981) (125)
Appraisal of the extrapancreatic actions of sulfonylureas. (1969) (124)
Gastrointestinal Carcinoids: Characterization by Site of Origin and Hormone Production (2000) (118)
Carcinoid tumors and syndrome. (1987) (114)
Glyburide: A Second‐generation Sulfonylurea Hypoglycemic Agent (1985) (98)
Midgut Carcinoid Tumors: CT Findings and Biochemical Profiles (1995) (96)
Detecting Pheochromocytoma: Defining the Most Sensitive Test (2006) (96)
Iodine‐131 metaiodobenzylguanidine treatment for metastatic carcinoid (2004) (92)
Endocrine and Metabolic Effects of Glybenclamide: Evidence for an Extrapancreatic Mechanism of Action (1971) (90)
Inhibition of hypoglycemia-induced cortisol secretion by the serotonin antagonist cyproheptadine. (1974) (90)
Endocrine function and glucose metabolism in patients with Parkinson's disease and their alternation by L-Dopa. (1971) (87)
Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. (1995) (80)
Carcinoids of unknown origin: comparative analysis with foregut, midgut, and hindgut carcinoids. (1998) (71)
Inhibition of insulin secretion by serotonin and dopamine: species variation. (1971) (69)
An Insulin Dependent Effect of Chronic Tolbutamide Administration on the Skeletal Muscle Carbohydrate Transport System (1969) (65)
Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors. (1986) (60)
Carcinoid Syndrome from Gastrointestinal Carcinoids without Liver Metastasis (1982) (60)
Serotonin inhibition of in vitro insulin release from golden hamster pancreas. (1970) (60)
Pancreatic biogenic amines and insulin secretion in health and disease. (1973) (53)
Radioimmunoassay of insulin in serum and plasma. (1973) (50)
The relationship between enzyme activity and the catecholamine content and secretion of pheochromocytomas. (1979) (47)
Increased dopamine production in patients with carcinoid tumors. (1985) (47)
Inhibition of Glucose Oxidase Paper Tests by Reducing Metabolites (1970) (45)
Potentiation of Insulin Secretion in Vitro by Serotonin Antagonists (1972) (45)
Carcinoid tumors: iodine-131 MIBG scintigraphy. (1989) (44)
Failure of 5-Hydroxytryptophan to Stimulate Prolactin and Growth Hormone Secretion in Man (1975) (42)
Pancreatic Islets: A Tissue Rich in Serotonin (1980) (40)
Mechanism of Epinephrine and Serotonin Inhibition of Insulin Release in the Golden Hamster in Vitro (1970) (38)
Species variation in the islets of langerhans (1979) (38)
Streptozotocin Treatment of Metastatic Carcinoid Tumors (1972) (38)
Flushing in the carcinoid syndrome and plasma kallikrein (1986) (38)
Effect of increased pancreatic islet norepinephrine, dopamine and serotonin concentration on insulin secretion in the Golden hamster (1980) (37)
Serotonin metabolism in patients with carcinoid tumors: Incidence of 5-hydroxytryptophan-secreting tumors (1978) (36)
Platelet uptake of the pheochromocytoma-scanning agent 131I-meta-iodobenzylguanadine. (1984) (36)
Tests for Glucosuria: An Analysis of Factors That Cause Misleading Results (1973) (35)
Effect of hyperthyroidism on insulin and glucose dynamics in rabbits. (1973) (35)
Foregut carcinoids: a clinical and biochemical analysis. (1999) (35)
Structural determinants of catecholamine action on in vitro insulin release. (1971) (34)
Catecholamine and serotonin content of foods: effect on urinary excretion of homovanillic and 5-hydroxyindoleacetic acid. (1987) (31)
Alterations in Plasma Norepinephrine Concentration During Surgical Resection of Pheochromocytoma (1978) (31)
Specificity of Serotonin Inhibition of Insulin Release from Golden Hamster Pancreas (1970) (30)
Treatment of metastatic pheochromocytoma with streptozocin. (1983) (30)
Growth hormone and prolactin secretion in the carcinoid syndrome (1975) (30)
Ammonium ion, a modulator of insulin secretion. (1971) (30)
Biological Activities of Tolbutamide and Its Metabolites: A Dissociation of Insulin-releasing and Hypoglycemic Activity (1969) (29)
Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. (1979) (29)
Falsely Elevated Urinary Excretion of Catecholamines and Metanephrines in Patients Receiving Labetalol Therapy (1987) (29)
Beta cell monoamines: further evidence for their role in modulating insulin secretion. (1974) (28)
Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytoma. (1991) (28)
Failure of indomethacin to inhibit growth of the R3230AC mammary tumor in rats. (1985) (28)
Acetaminophen administration interferes with urinary metanephrine (and catecholamine) determinations. (1985) (27)
Characterization of pancreatic islet monoamine oxidase. (1975) (26)
Adrenal function in the carcinoid syndrome: effects of the serotonin antagonist cyproheptadine. (1975) (25)
Enhancement of insulin secretion in adult onset diabetics by methysergide maleate: evidence for an endogenous biogenic monoamine mechanism as a factor in the impaired insulin secretion in diabetes mellitus. (1971) (25)
Diagnostic and therapeutic considerations in a hypercalcemic dog with multiple endocrine neoplasia. (1995) (25)
Species Variation in Pancreatic Islet Monoamine Uptake and Action (1977) (24)
Glucose Intolerance in the Carcinoid Syndrome (1975) (24)
Pseudocystic liver metastases in patients with carcinoid tumors: report of three cases. (1984) (24)
Serotonin metabolism in patients with carcinoid tumors: incidence of 5-hydroxytryptophan-secreting tumors. (1978) (23)
Radioenzymatic assay of platelet serotonin, dopamine and norepinephrine in subjects with normal and increased serotonin production. (1981) (23)
Pheochromocytoma-induced cardiomyopathy. (2000) (23)
The role of cortisol and growth hormone in the counter-regulation of insulin-induced hypoglycemia. (1975) (22)
Specificity of nucleotide-induced insulin secretion. (1974) (22)
Structural determinants of indole amine action on in vitro insulin release. (1972) (19)
Cushing's Disease: A Hypothalamic Flush? (1975) (19)
Serum prostaglandin F2α concentration in the carcinoid syndrome (1974) (19)
USE OF 123IODINE METAIODOBENZYLGUANIDINE SCINTIGRAPHY FOR THE DIAGNOSIS OF A PHEOCHROMOCYTOMA IN A DOG (1993) (19)
Role of pancreatic monoamines in the impaired insulin secretion of the fasting state. (1973) (18)
An unusual pheochromocytoma associated with an androgen secreting adrenocortical adenoma. Evaluation of its polypeptide hormone, catecholamine, and enzyme characteristics (1987) (18)
Characteristics of the Dopaminergic and Noradrenergic Systems of the Pancreatic Islets (1979) (18)
Ileal carcinoid tumors stimulating Crohn's disease: incidence among 176 consecutive cases of ileal carcinoid. (1997) (18)
The nature of the interaction of amines with the pancreatic beta cell to influence insulin secretion. (1971) (18)
INHIBITORY EFFECT OF SEROTONIN ANTAGONISTS ON GROWTH HORMONE RELEASE IN ACROMEGALIC PATIENTS (1976) (18)
Effect of ethanol and its metabolites on insulin secretion. (1974) (17)
Gastrointestinal and metabolic function in patients with the carcinoid syndrome (1977) (17)
Phenylethanolamine-N-methyltransferase activity determines the epinephrine concentration of pheochromocytomas. (1981) (17)
Effect of fasting on insulin secretion and action in mice. (1970) (16)
Elevated hypothalamic norepinephrine content in mice with the hereditary obese-hyperglycemic syndrome. (1979) (16)
Peyronie's disease--a presenting complaint of the carcinoid syndrome. (1973) (16)
Effect of Age on Intravenous Glucose Tolerance and Insulin Secretion * (1976) (15)
Serotonin metabolism and platelet monoamine oxidase activity in patients with medullary carcinoma of the thyroid and pheochromocytoma (1979) (15)
Monoamine and diamine oxidase activity in the diagnosis of carcinoid tumors (1985) (14)
Review of glyburide after one year on the market. (1985) (14)
Mechanisms of Catecholamine Inactivation by the Endocrine Pancreas (1974) (13)
Alterations of pituitary-gonadal function in the carcinoid syndrome (1974) (12)
Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit. (1998) (12)
Case report: chylous ascites and carcinoid tumors: possible association of two rare disorders. (1988) (12)
Monoamine oxidase inhibition: possible mechanism for cyproheptadine-induced alterations in insulin secretion. (1974) (12)
Monoamine oxidase inhibitors: Nature of their interaction with rabbit pancreatic islets to alter insulin secretion (1975) (11)
Glucose Metabolism and Insulin Secretion in the Carcinoid Syndrome1 (1972) (11)
Carcinoid and chylous ascites: An unusual association (2002) (11)
Carcinoid of the ampulla of Vater presenting as acute pancreatitis. (1996) (11)
Adult respiratory distress syndrome in a pregnant patient with a pheochromocytoma (1985) (11)
Effects of Amino Acids, Epinephrine and Heparin upon the Radioimmunoassay of Insulin in Plasma (1973) (10)
Monoamine Oxidase, Catechol-O-methyltransferase, and Norepinephrine Levels in Mice with the Hereditary Obese-hyperglycemic Syndrome (1978) (10)
A role of estrogens and insulin binding in the dietary lipid alteration of R3230AC mammary carcinoma growth in rats. (1985) (10)
Effect of hyper- and hypothyroidism on platelet monoamine oxidase activity and serotonin metabolism. (1977) (9)
Transplantation of insulinoma into the diabetic Syrian hamster. (1980) (9)
Preparation of islets of langerhans from rabbits and hamsters by the collagenase digestion technique (1975) (9)
Detection and treatment of carcinoid tumors. (1988) (9)
Elevated platelet norepinephrine concentration in patients with pheochromocytomas. (1981) (9)
Effects of diabetes mellitus and chemical sympathectomy on tissue monoamine oxidase activity and norepinephrine concentration in the golden hamster. (1981) (8)
The effect of harmine and other monoamine oxidase inhibitors on N-acetyltransferase activity. (1979) (8)
Interference with measurement of 3-methoxy-4-hydroxymandelic acid and 5-hydroxyindoleacetic acid by reducing metabolites. (1974) (8)
Plasma norepinephrine response to standing in patients with pheochromocytoma or medullary carcinoma of the thyroid. (1979) (8)
Golden hamster pancreatic islets: a tissue rich in monoamine oxidase. (1980) (8)
Serum-insulin levels in patients on insulin. (1971) (8)
Effect of cyproheptadine administration on insulin secretion in acromegalic, diabetic and normal subjects. (1975) (7)
Carcinoid and other metabolically active tumors in the elderly. (1987) (7)
Effect of ether, chloroform and carbon dioxide on monoamine inactivation (1976) (7)
99mTc-pyrophosphate bone scans in patients with metastatic carcinoid tumors. (1977) (7)
Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice (1988) (7)
ADDISON'S DISEASE AND HYPERTHYROIDISM. REPORT OF A CASE AND DEMONSTRATION OF CIRCULATING ADRENAL AND THYROID ANTIBODIES. (1965) (7)
Urinary homogentisic acid: determination by thin-layer chromatography. (1973) (7)
Effect of metastatic cancer on platelet monoamine oxidase activity and serotonin metabolism (1979) (6)
Diagnosis and management of pheochromocytoma. (1989) (6)
Monoamine oxidase and catechol-O-methyl transferase activity in Tetrahymena. (1977) (6)
Antagonism of catecholamine inhibition of insulin secretion by methysergide (1972) (6)
Effect of chronic tolbutamide administration on normal and obese-hyperglycemic mice: evidence for post-receptor potentiation of insulin action. (1982) (6)
Tissue norepinephrine concentration in spontaneously diabetic Chinese hamsters. (1988) (5)
Monoamine oxidase inhibitors: nature of their interaction with rabbit pancreatic islets to alter insluin secretion. (1975) (5)
IMMUNOLOGICAL CONSEQUENCES OF TRANSPLANTING RAT INSULINOMAS (1980) (5)
Carcinoembryonic Antigen and Carcinoid Tumors (1975) (5)
Effect of oral contraceptives on platelet monoamine oxidase, monoamine excretion, and adrenocortical function (1976) (5)
Further studies of methamphetamine-induced insulin release. (1975) (5)
Histamine antagonists and carcinoid flush. (1980) (5)
Metabolic acidosis in patients with the carcinoid syndrome: Treatment with parachlorophenylalanine (1982) (4)
Potentiation of Tolbutamide-mediated Insulin Release in Adult Onset Diabetics by Methysergide Maleate (1974) (4)
Inhibition of pancreatic islet monoamine oxidase by adrenergic antagonists and ethanol. (1975) (4)
Effect of glucose and fat feeding on norepinephrine turnover in rats (2005) (4)
Catecholamine metabolism in the carcinoid syndrome. (1974) (4)
Effect of hyperprolactinemia on pituitary-adrenal function. (1978) (4)
The Carcinoid Syndrome (1993) (4)
Effect of chronic hyperserotoninemia on platelet monoamine oxidase activity and serotonin uptake. (1979) (4)
The role of altered tissue norepinephrine concentration in the hereditary obese-hyperglycemic syndrome of mice. (1979) (4)
Thin-layer chromatography of homovanillic acid with use of toluene instead of benzene. (1988) (3)
Effect of intravenous glucose and insulin on plasma tryptophan and tyrosine concentrations in normal subjects and patients with carcinoid tumors. (1976) (3)
Glucose metabolism and insulin secretion in the carcinoid syndrome. (1972) (3)
Urinary free Cortisol excretion in patients with metastatic cancer (1979) (3)
Carcinoid Liver Metastases Accuracy of Radionuclide Liver/Spleen Imaging Compared to Computed Tomography (1987) (3)
Effects of aging on monoamine oxidase activity of mouse and rabbit tissues. (1978) (3)
Plasma amino acids in patients with the carcinoid syndrome (1976) (3)
Therapeutic Doses of Cyproheptadine Do Not Inhibit Monoamine Oxidase in Man (1976) (3)
Effect of estradiol-17 beta on glucose and proline uptake in plasma membrane vesicles from the R3230AC rat mammary carcinoma. (1985) (3)
Radioactive iodine treatment of intractable angina pectoris. (1965) (3)
Effect of pharmacological agents and fasting on pancreatic islet norepinephrine in the golden hamster (1979) (3)
Carcinoid tumors: effect on thyroid function (1973) (3)
I-131 MIBG imaging of carcinoid tumors (1985) (2)
URINARY FREE CORTISOL EXCRETION IN PATIENTS WITH HYPERSEROTONINAEMIA FROM THE CARCINOID SYNDROME (1979) (2)
Carcinoid arthropathy. (1974) (2)
Adrenal-cortical function in patients with medullary carcinoma of the thyroid and pheochromocytoma. (1979) (2)
Metabolic and endocrine studies in identical diabetic twins. (1974) (2)
Biochemical composition of edge and center of malignant hamster insulinoma. (1984) (2)
Plasma para-chlorophenylalanine measurements with gas-liquid chromatography. Methodological and pharmacological studies. (1977) (2)
Monoamine oxidase and catechol-o-methyltransferase activity in hamster and rat insulinomas (1979) (2)
Steady state glucose dynamics in hyperthyroid rabbits. (1973) (2)
Plasma and tumor dopamine-beta-hydroxylase activity in patients with familial pheochromocytomas. (1978) (2)
Carcinoid Tumors With Supraclavicular-Lymph Node Metastasis (1975) (2)
Pituitary-gonadal function in the carcinoid syndrome: effect of parachlorophynylalanine therapy. (1977) (1)
The practical use of thyroid function tests. (1977) (1)
Case Report Tissue Levels of Monoamines and Monoamine Metabolizing Enzymes in Medullary Carcinoma and Other Thyroid Diseases (1981) (1)
Biochemical and ultrastructural differences between muco‐epidermoid and carcinoid tumors of the bronchus (1988) (1)
Limitations of angiography for mesenteric ischemia caused by midgut carcinoid tumors (1989) (1)
Streptozotocin Therapy for Malignant Pheochromocytoma-Reply (1985) (1)
99mTc-pyrophosphate bone scans and endocrinologic evaluation in a patient with eosinophilic granuloma. (1975) (1)
Levodopa and tests for urinary glucose. (1970) (1)
Serum prostaglandin F-2 alpha concentration in the carcinoid syndrome. (1974) (1)
Hyperseritoninemia—A Cause of Secondary Diabetes Mellitus. (1972) (1)
Tissue levels of monoamines and monamine metabolizing enzymes in medullary carcinoma and other thyroid diseases. (1981) (1)
Effects of food restriction on mice with the hereditary obese-hyperglycemic syndrome (2007) (1)
Surgery in patients with unsuspected pheochromocytomas (1989) (1)
Error in description of 5-HIAA method. (1972) (0)
Therapy of malignant hamster insulinomas with monoamine precursors (1981) (0)
Clinical application of umbilical and uterine blood velocity measurements (1990) (0)
CHAPTER 12 – Oral Hypoglycemics (1981) (0)
Radioimmunoassay of InsulininSerumand Plasma (1973) (0)
Letter: Carcinoembryonic antigen and carcinoid tumors. (1975) (0)
Editorial: Cushing's disease: a hypothalamic flush? (1975) (0)
Aberrations in tissue norepinephrine ceoncentrations in obese hyperglycemic mice. Abstr. (1979) (0)
Misleading tests for glycosuria. (1973) (0)
Effect of insulin excess and deficiency on norepinephrine turnover in rats (2005) (0)
Letter: Carcinoid tumors with supraclavicular-lymph node metastasis. (1975) (0)
Effect of the monoamine oxidase inhibitors pargyline and clorgyline on the hyperphagia of obese-hyperglycemic mice. Abstr. (1981) (0)
Comparison of monoamine oxidase in golden hamster islets and insulinoma. (1983) (0)
Reliability of copper reduction methods for quantitation of glucosuria (2007) (0)
Change in Plasma Alpha-Tocopherol Associations with Attenuated Pulmonary Function Decline and with CYP4F2 Missense Variation (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jerome M. Feldman?

Jerome M. Feldman is affiliated with the following schools:

Duke University